Track market-moving stories before they get noisy

Platform to accelerate investment in next generation ag-tech innovation

, /PRNewswire/ -- Vylor, the advanced seed and genetics company that will spin-off from Corteva on October 1, 2026, today announced the launch of Vylor Edge, a new investment platform dedicated to accelerating the development of advanced technologies in global agriculture. Vylor Edge will collaborate with start-ups, entrepreneurs, universities and the wider innovation ecosystem through equity investments and strategic partnerships. 

"Vylor Edge will partner with the global scientific community to deliver breakthrough innovations that advance global agriculture and mitigate key production challenges," said Sam Eathington, chief technology officer of the future Vylor. "Pairing Vylor's world class expertise with other technology leaders from around the world will help drive innovation and equip farmers with the tools they need to be successful."

Vylor Edge will initially focus on identifying opportunities across strategic verticals aligned with Vylor's priorities, including gene editing and advanced breeding; protein engineering; as well as artificial intelligence and digital technology platforms. It will also explore opportunities in other areas and sectors to harness technologies applicable to Vylor's business and mission to help farmers feed and fuel the world.

"We are excited to collaborate with entrepreneurs who can benefit from the deep expertise of our dedicated team, as well as Vylor's leading R&D capabilities, global footprint, and go-to-market infrastructure," said Mat Muller,  head of Vylor Edge. "We look forward to supporting the development and commercialization of promising technologies and delivering new innovations to growers."

The Vylor Edge portfolio will be launched with a strong foundation of investments and collaborations that were previously part of Corteva Catalyst™ and are now transitioning to Vylor as part of the company's spin-off from Corteva. Through Vylor Edge, Vylor will continue to support and expand these partnerships while identifying new opportunities to accelerate innovation across global agriculture.

About Corteva

Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed and crop protection products. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

Cautionary statement

This release contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like "may," "expects," "will," "aims," "believes," "intends," or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the parties' expectations related to regulatory matters, product development and commercialization, product offerings and product, financial or sustainability performance are forward-looking statements. No obligation to update or revise any forward-looking statement, except as required by applicable law, is hereby undertaken and any such obligation is specifically disclaimed. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements or other estimates is included in the "Risk Factors" section of Corteva's Annual Report on Form 10-K, and as modified by subsequent reports on Form 10-Q and Current Reports on Form 8-K and Vylor's Registration Statement on Form 10.

SOURCE Corteva Agriscience

Investors interested in Agriculture - Operations stocks are likely familiar with Dole (DOLE) and Corteva, Inc. (CTVA). But which of these two stocks offers value investors a better bang for their buck right now?

Bank of New York Mellon Corp bought a new position in Corteva, Inc. (NYSE:CTVA – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,633,924 shares of the company’s stock, valued at approximately $392,447,000. Bank of New York Mellon Corp owned 0.69% of Corteva at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CTVA. JPL Wealth Management LLC bought a new stake in shares of Corteva in the 3rd quarter worth $25,000. Garton & Associates Financial Advisors LLC bought a new position in Corteva during the fourth quarter valued at about $27,000. Bank of Jackson Hole Trust bought a new position in Corteva during the fourth quarter valued at about $28,000. Cornerstone Financial Management LLC acquired a new position in Corteva during the fourth quarter worth about $29,000. Finally, Elevation Wealth Partners LLC grew its holdings in Corteva by 334.6% during the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after acquiring an additional 261 shares during the period. 81.54% of the stock is owned by institutional investors.

Corteva Stock Performance Shares of NYSE CTVA opened at $81.84 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97. The business’s 50-day moving average price is $82.13 and its two-hundred day moving average price is $80.21. The company has a market capitalization of $54.60 billion, a P/E ratio of 54.20, a price-to-earnings-growth ratio of 2.44 and a beta of 0.57.

Corteva (NYSE:CTVA – Get Free Report) last posted its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. The company had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year. Corteva Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is presently 47.68%.

Analysts Set New Price Targets A number of equities research analysts have weighed in on the stock. Weiss Ratings downgraded shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. CICC Research lifted their price objective on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $101.00 target price on shares of Corteva in a report on Monday, August 3rd. JPMorgan Chase & Co. increased their target price on shares of Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Finally, Mizuho raised their target price on shares of Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $91.50.

Get Our Latest Report on Corteva

Corteva Company Profile (Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Articles Five stocks we like better than Corteva Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.

Advisors Capital Management LLC bought a new position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 9,002 shares of the company’s stock, valued at approximately $762,000.

Other hedge funds have also modified their holdings of the company. Arbejdsmarkedets Tillaegspension purchased a new position in Corteva during the fourth quarter worth about $23,679,000. Leonteq Securities AG acquired a new position in shares of Corteva in the fourth quarter worth $2,350,000. Brandes Investment Partners LP increased its position in shares of Corteva by 1.1% during the fourth quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock worth $155,009,000 after acquiring an additional 24,985 shares during the period. Twin Capital Management Inc. raised its stake in shares of Corteva by 178.9% in the fourth quarter. Twin Capital Management Inc. now owns 25,394 shares of the company’s stock valued at $1,702,000 after acquiring an additional 16,288 shares in the last quarter. Finally, Renaissance Technologies LLC purchased a new position in Corteva in the first quarter valued at $1,222,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes A number of brokerages have commented on CTVA. Citigroup increased their price objective on shares of Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. Weiss Ratings lowered Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Barclays lifted their price objective on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a report on Thursday, June 11th. BNP Paribas Exane raised their price objective on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Finally, Oppenheimer increased their price objective on Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and an average target price of $91.50.

Get Our Latest Stock Report on CTVA Corteva Price Performance NYSE CTVA opened at $81.84 on Friday. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97. The stock has a market capitalization of $54.60 billion, a P/E ratio of 54.20, a P/E/G ratio of 2.44 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The business’s fifty day moving average is $82.13 and its two-hundred day moving average is $80.21.

Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter in the previous year, the company earned $2.20 EPS. The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Corteva Company Profile (Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Further Reading Five stocks we like better than Corteva Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.

Bell & Brown Wealth Advisors LLC bought a new position in Corteva, Inc. (NYSE:CTVA – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 14,533 shares of the company’s stock, valued at approximately $1,231,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. BlackRock Inc. purchased a new stake in shares of Corteva during the 2nd quarter valued at about $4,560,180,000. Harris Associates L P lifted its holdings in Corteva by 168.1% in the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after acquiring an additional 10,675,052 shares during the period. Norges Bank bought a new position in shares of Corteva in the 4th quarter worth approximately $504,001,000. Royal Bank of Canada grew its position in Corteva by 202.1% during the first quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock valued at $624,362,000 after buying an additional 4,989,371 shares during the period. Finally, Bank of New York Mellon Corp purchased a new stake in Corteva during the second quarter valued at approximately $392,447,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Price Performance NYSE CTVA opened at $78.51 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97. The company has a market cap of $52.38 billion, a price-to-earnings ratio of 51.99, a PEG ratio of 2.39 and a beta of 0.57. The stock’s fifty day moving average price is $81.92 and its 200 day moving average price is $80.15.

Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.06. The company had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. Corteva’s quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year. Corteva Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio is currently 47.68%.

Wall Street Analysts Forecast Growth A number of brokerages have commented on CTVA. UBS Group reduced their price target on Corteva from $89.00 to $85.00 and set a “neutral” rating for the company in a research report on Tuesday. Morgan Stanley upped their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Oppenheimer increased their target price on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. JPMorgan Chase & Co. upped their price target on shares of Corteva from $77.00 to $83.00 and gave the stock a “neutral” rating in a report on Monday, August 3rd. Finally, Weiss Ratings lowered Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, Corteva currently has an average rating of “Moderate Buy” and an average price target of $91.50.

Check Out Our Latest Stock Analysis on CTVA

Corteva Company Profile (Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

See Also Five stocks we like better than Corteva Bloom Energy’s AI Surge Meets a Valuation Reality Check Target Is Winning Shoppers Back—Can the Rally Reach $180? IonQ’s Space Contract Points to a New Frontier for Quantum Investors Is Apple’s AI Strategy Smarter Than Skeptics Think? Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways Corteva's Seed sales rose 4%, supported by technology demand, pricing and improved royalty economics.Corteva raised 2026 EBITDA guidance to $4.1-$4.3 billion as productivity actions boost earnings.Corteva faces Crop Protection pricing pressure and execution risks ahead of its planned Oct. 1 separation. Corteva, Inc. (CTVA - Free Report) is showing improving earnings momentum as technology adoption, productivity actions and a stronger Seed business support growth. However, the stock’s valuation and ongoing Crop Protection pricing pressures keep the risk-reward balance more measured. The stock currently carries a Zacks Rank #3 (Hold), with a price target of $81.00 versus a share price of $76.22 as of Aug. 11, 2026.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Corteva delivered a solid first half of 2026, with net sales increasing 4% year over year to $11.28 billion and operating EBITDA rising 10% to $3.70 billion. Operating EPS increased 14% to $3.80. Management raised its full-year outlook and now expects operating EBITDA of $4.1-$4.3 billion and operating EPS of $3.60-$3.80 per share.

Growth Drivers Remain in PlaceThe Seed segment continues to be the primary growth contributor. First-half Seed net sales increased 4% to $7.56 billion, helped by higher price/mix, demand for differentiated germplasm and trait technologies and improved royalty economics. Segment operating EBITDA increased 11% to $3 billion, supported by pricing actions and lower royalty expense.

Corteva’s Crop Protection business is also benefiting from new product adoption. In the first half of 2026, Crop Protection sales increased 3%, with volume growth from new products helping offset a 3% pricing decline caused by competitive conditions, particularly in Latin America.

Productivity initiatives remain another earnings driver. Management cited more than $160 million in cost improvements from lower input costs, manufacturing efficiencies and productivity programs during the first half of 2026.

Separation Adds a Near-Term Execution RiskCorteva is preparing to separate its businesses into two standalone public companies, targeting completion on Oct. 1, 2026. Management has reported that run-rate dis-synergies are largely offset, but remaining steps include final capital structures, Form 10 effectiveness and IT separation activities.

The transition could require additional management focus as Corteva prepares both businesses to operate independently. The company included a $25 million headwind in 2026 guidance related to separation timing.

Valuation Leaves Less Room for ErrorCorteva’s valuation reflects some of the expected earnings improvement. The stock trades at 19.6X forward 12-month earnings, with a PEG ratio of 2.2X. Its Zacks Style Scores include a Value Score of D, Growth Score of F, Momentum Score of C and VGM Score of F.

Image Source: Zacks Investment Research

While earnings growth expectations have improved, valuation remains a concern if Crop Protection pricing pressure persists or separation-related costs weigh on results.

Corteva competes within the broader agricultural sector alongside companies such as Archer Daniels Midland Company (ADM - Free Report) and Adecoagro S.A. (AGRO - Free Report) . Corteva focuses primarily on agricultural technology solutions, including seeds and crop protection products, while ADM operates a large-scale agricultural processing and commodities platform and AGRO has exposure to farming, sugar, ethanol and agricultural production assets.

Bottom LineCorteva’s improving fundamentals are supported by Seed technology demand, new Crop Protection products and cost discipline. The company has raised its 2026 outlook and continues to execute on its separation plan. However, elevated valuation, competitive pricing pressure and execution risks around the separation limit near-term upside potential.

Given the balance between improving earnings trends and valuation concerns, CTVA appears more suitable for investors seeking exposure to agricultural technology growth but willing to accept moderate near-term upside potential.

, /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announced today that Vylor Inc., a Delaware corporation and its wholly owned subsidiary ("Vylor"), has commenced private offers to exchange (with respect to each series, an "Exchange Offer" and together, the "Exchange Offers") any and all of the outstanding senior notes of the series listed in the table below issued by EIDP, Inc., a Delaware corporation and a wholly owned subsidiary of Corteva ("EIDP" and such notes, collectively, the "EIDP Notes"), to the extent held by eligible holders, for a corresponding series of notes to be newly issued by Vylor (collectively, the "Vylor Notes"). As previously disclosed, Corteva's Board of Directors is pursuing a plan to separate Corteva into two independent, publicly traded companies, one comprising its current crop protection business and the other comprising its current seed business to be owned and conducted, directly or indirectly, by Vylor (the "Separation"). The Exchange Offers and Consent Solicitations (as defined below) are being made in connection with the planned Separation. Each Exchange Offer and Consent Solicitation is conditioned upon, among other things, consummation of the Separation and the receipt, by the applicable Early Tender Deadline (as defined below), of the Requisite Consents (as defined below) to the Proposed EIDP Base Indenture Amendments (as defined below). The Separation is subject to the satisfaction or waiver of certain customary conditions, and Corteva's Board of Directors has the discretion to abandon or to alter the terms of the planned Separation. As publicly announced by Corteva on July 30, 2026, the Separation is currently expected to be consummated on or about October 1, 2026, subject to satisfaction or waiver of the conditions thereto.

The Exchange Offers and Consent Solicitations are being made upon the terms and conditions set forth in an exchange offer memorandum and consent solicitation statement, dated August 6, 2026 (the "Offering Memorandum"), copies of which will be made available to holders of the EIDP Notes eligible to participate in the Exchange Offers and Consent Solicitations.

The Vylor Notes will have the same interest payment dates, maturity date and interest rate as the EIDP Notes of the corresponding series. In addition to the Vylor Notes, eligible holders of EIDP Notes tendered by the applicable Early Tender Deadline and not validly withdrawn before the applicable Withdrawal Deadline (as defined below) will also receive the applicable Cash Consideration (as defined below). The following table sets forth the applicable Total Exchange Consideration (as defined below), which includes the Cash Consideration, and the applicable Exchange Consideration (as defined below) being offered for a series of EIDP Notes:

Total Exchange
Consideration for
EIDP Notes Validly
Tendered by the
Early Tender
Deadline and Not
Validly Withdrawn by
the Withdrawal
Deadline

Exchange
Consideration
for EIDP Notes
Validly
Tendered After
the Early
Tender
Deadline

Title of
Series of
EIDP
Notes

CUSIP No.
and ISIN of
EIDP Notes

Aggregate
Principal
Amount of
EIDP Notes
Outstanding

Vylor Notes
to be
Issued in
Exchange
for EIDP
Notes

Principal
Amount
of Vylor
Notes (1)

Cash
Consideration
(2)

Principal
Amount of
Vylor Notes
(3)

2.300% Senior Notes due 2030

263534CP2 US263534CP24

$

500,000,000

2.300% Senior Notes due 2030

$1,000

$2.50 to $5.00

$970

5.125% Senior Notes due 2032

263534CS6 US263534CS62

$

500,000,000

5.125% Senior Notes due 2032

$1,000

$2.50 to $5.00

$970

4.800% Senior Notes due 2033

263534CR8 US263534CR89

$

600,000,000

4.800% Senior Notes due 2033

$1,000

$2.50 to $5.00

$970

Principal amount of the applicable series of Vylor Notes issued in exchange for each $1,000 principal amount of EIDP Notes of the corresponding series validly tendered by the applicable Early Tender Deadline and not validly withdrawn by the applicable Withdrawal Deadline and accepted for exchange. Per $1,000 principal amount of the applicable series of EIDP Notes validly tendered by the applicable Early Tender Deadline and not validly withdrawn by the applicable Withdrawal Deadline and accepted for exchange, the applicable Cash Consideration will be an amount equal to the product of $2.50 multiplied by a fraction, the numerator of which is the aggregate principal amount of such series of EIDP Notes outstanding as of such Early Tender Deadline and the denominator of which is the aggregate principal amount of such series of EIDP Notes validly tendered by such Early Tender Deadline and not validly withdrawn by the applicable Withdrawal Deadline. As a result, the applicable Cash Consideration for a series of EIDP Notes will range from $2.50 per $1,000 principal amount (if all eligible holders of such series of EIDP Notes tender) to approximately $5.00 per $1,000 principal amount (if eligible holders of a simple majority of the aggregate principal amount of such series of EIDP Notes tender). The applicable Exchange Consideration does not include, and eligible holders tendering after the applicable Early Tender Deadline will not be eligible to receive, any Cash Consideration. The applicable Exchange Consideration involves the issuance of $970 principal amount of the applicable series of Vylor Notes, as opposed to $1,000 principal amount of such Vylor Notes, for each $1,000 principal amount of EIDP Notes of the corresponding series validly tendered after the applicable Early Tender Deadline and accepted for exchange. Concurrently with the Exchange Offers, Vylor is soliciting consents (with respect to the EIDP Base Indenture (as defined below) and the applicable EIDP Supplemental Indenture (as defined below) governing a series of EIDP Notes, a "Consent Solicitation" and together, the "Consent Solicitations") from eligible holders of EIDP Notes, on behalf of EIDP, to adopt certain proposed amendments to the base indenture (the "EIDP Base Indenture") and the supplemental indentures thereto (each, an "EIDP Supplemental Indenture") governing the EIDP Notes. The proposed amendments to the EIDP Base Indenture (the "Proposed EIDP Base Indenture Amendments") would eliminate substantially all of the restrictive covenants and events of default (other than payment-related and bankruptcy-related events of default) from the EIDP Base Indenture. Approval of the Proposed EIDP Base Indenture Amendments requires consents from the holders of at least a majority of the aggregate principal amount of all the EIDP Notes, voting as a single class (the "Requisite Consents"). The Exchange Offers are conditioned upon, among other things, receipt, by the applicable Early Tender Deadline, of the Requisite Consents to the Proposed EIDP Base Indenture Amendments. The proposed amendments with respect to each EIDP Supplemental Indenture (the "Proposed EIDP Supplemental Indenture Amendments" and, together with the Proposed EIDP Base Amendments, the "Proposed Amendments") would eliminate the offer to repurchase upon change of control provisions from the applicable EIDP Supplemental Indenture. Approval of the Proposed EIDP Supplemental Indenture Amendments requires consents from the holders of at least a majority of the aggregate principal amount of the applicable series of EIDP Notes (the "Majority Consents"). The Exchange Offers are not conditioned upon the receipt of the Majority Consents with respect to any EIDP Supplemental Indenture. When an eligible holder validly tenders their EIDP Notes in the applicable Exchange Offer, they are automatically treated as having validly delivered the related consents to the Proposed Amendments with respect to such EIDP Notes. Eligible holders will not be permitted to tender their EIDP Notes without delivering related consents or to deliver related consents without tendering their EIDP Notes.

Each Exchange Offer and Consent Solicitation will expire at 5:00 p.m., New York City time, on September 3, 2026, unless extended or earlier terminated (such date and time, as they may be extended, the "Expiration Date"). Tenders of a series of EIDP Notes may be validly withdrawn at or prior to 5:00 p.m., New York City time, on August 19, 2026, unless extended or earlier terminated with respect to the applicable Exchange Offer (such date and time, as they may be extended, the "Withdrawal Deadline"), but tenders of such EIDP Notes not so validly withdrawn will thereafter be irrevocable, except in certain limited circumstances where additional withdrawal rights are required by law. A valid withdrawal of the applicable series of EIDP Notes at or prior to 5:00 p.m., New York City time, on August 19, 2026 (such date and time, as they may be extended to any date and time that is no later than the Withdrawal Deadline, the "Consent Revocation Deadline") will also constitute the revocation of the related consents. With respect to a series of EIDP Notes, consents may not be revoked after the applicable Consent Revocation Deadline. Vylor reserves the right to terminate, withdraw, amend or extend an Exchange Offer and Consent Solicitation in its sole discretion, subject to the terms and conditions set forth in the Offering Memorandum.

Subject to the terms and conditions set forth in the Offering Memorandum, for each $1,000 principal amount of the applicable series of EIDP Notes validly tendered in the applicable Exchange Offer by 5:00 p.m., New York City time, on August 19, 2026, unless extended or earlier terminated with respect to the applicable Exchange Offer and Consent Solicitation (such date and time, as they may be extended, the "Early Tender Deadline"), and not validly withdrawn by the applicable Withdrawal Deadline, each eligible holder of EIDP Notes will be eligible to receive (i) Vylor Notes of the corresponding series in an equal principal amount as such series of EIDP Notes tendered and accepted for exchange and (ii) a cash payment of an amount equal to the product of $2.50 multiplied by a fraction, the numerator of which is the aggregate principal amount of such series of EIDP Notes outstanding as of the applicable Early Tender Deadline and the denominator of which is the aggregate principal amount of such series of EIDP Notes validly tendered by such Early Tender Deadline and not validly withdrawn by the applicable Withdrawal Deadline (the "Cash Consideration" and, together with such amount of Vylor Notes, the "Total Exchange Consideration"). As a result, the applicable Cash Consideration for a series of EIDP Notes will range from $2.50 per $1,000 principal amount (if all eligible holders of such series of EIDP Notes tender) to approximately $5.00 per $1,000 principal amount (if eligible holders of a simple majority of the aggregate principal amount of such series of EIDP Notes tender).

Eligible holders who validly tender their EIDP Notes after the applicable Early Tender Deadline but on or prior to the Expiration Date will be eligible to receive $970 principal amount of the applicable series of Vylor Notes per $1,000 principal amount of the corresponding series of EIDP Notes validly tendered (the "Exchange Consideration") but no Cash Consideration.

In addition, all eligible holders whose EIDP Notes are validly tendered and accepted for exchange in the Exchange Offers and Consent Solicitations will receive a cash payment equal to the accrued and unpaid interest on their EIDP Notes accepted for exchange from the last interest payment date of the applicable EIDP Notes preceding the Settlement Date up to, but excluding, the Settlement Date.

Assuming the conditions to the Exchange Offers and Consent Solicitations are satisfied or (to the extent permitted) waived, settlement of the Exchange Offers is expected to occur on or about the second business day following the Expiration Date and substantially simultaneously with the consummation of the Separation, unless Vylor extends or terminates the Exchange Offers (such date and time, as the same may be extended, the "Settlement Date"). Accordingly, Vylor may, in its discretion, extend each of the Expiration Date and the Settlement Date as necessary to maintain such sequencing. Interest on the applicable series of Vylor Notes issued in the related Exchange Offer will accrue from (and including) the Issue Date (the date on which such Vylor Notes are issued in exchange for the corresponding series of EIDP Notes).

The Vylor Notes to be issued in the Exchange Offers will be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. No tender of EIDP Notes of any series will be accepted if it would result in the issuance of less than $2,000 principal amount of the corresponding series of Vylor Notes. If the principal amount of the applicable series of Vylor Notes that would otherwise be required to be delivered in exchange for a tender of the corresponding series of EIDP Notes would not equal $2,000 or an integral multiple of $1,000 in excess thereof, then the principal amount of such Vylor Notes will be rounded down to $2,000 or the nearest integral multiple of $1,000 in excess thereof, and Vylor will pay cash (in lieu of such Vylor Notes not delivered) equal to the remaining portion of the applicable Exchange Consideration for such corresponding series of EIDP Notes plus accrued and unpaid interest with respect to that portion to, but not including, the Settlement Date.

Vylor's obligation to accept and exchange any EIDP Notes validly tendered pursuant to the applicable Exchange Offer is subject to, and conditioned upon, the satisfaction or (to the extent permitted) waiver of certain conditions as set forth in the Offering Memorandum. Each Exchange Offer and Consent Solicitation is conditioned upon, among other things, (i) the consummation of the Separation and (ii) the receipt, by the applicable Early Tender Deadline, of the Requisite Consents to adopt the Proposed EIDP Base Indenture Amendments. Receipt of the Majority Consents to adopt the Proposed EIDP Supplemental Indenture Amendments is not a condition to the consummation of any of the Exchange Offers and Consent Solicitations. Other than the Separation (without the consummation of which the Exchange Offers and Consent Solicitations will not be consummated, neither the applicable Exchange Consideration nor the applicable Total Exchange Consideration will be delivered, and the Proposed Amendments contemplated by the Consent Solicitations will not become effective), Vylor may generally waive any condition with respect to the Exchange Offers and Consent Solicitations, in its sole discretion, at any time prior to the Expiration Date.

The Exchange Offers and Consent Solicitations are being made only to holders of EIDP Notes who satisfy the eligibility conditions described under "Disclaimer" below. Holders of EIDP Notes who desire a copy of the eligibility letter should contact D.F. King & Co., Inc., the information agent and exchange agent for the Exchange Offers and Consent Solicitations, by phone at (800) 283-9185 or by email at [email protected]. Banks and brokers should call (646) 461-2610. The eligibility letter may also be found here: www.dfking.com/vylor. D.F. King & Co., Inc. will also provide copies of the Offering Memorandum to eligible holders of EIDP Notes.

Holders of EIDP Notes are advised to check with any bank, securities broker or other intermediary through which they hold EIDP Notes as to when such intermediary needs to receive instructions from a holder in order for that holder to be able to participate in, or (in the circumstances in which revocation is permitted) revoke their instruction to participate in, the Exchange Offers and Consent Solicitations before the deadlines specified herein and in the Offering Memorandum. The deadlines set by each clearing system for the submission and withdrawal of exchange instructions will also be earlier than the relevant deadlines specified herein and in the Offering Memorandum.

Disclaimer

This press release is issued pursuant to Rule 135c under the Securities Act of 1933, as amended (the "Securities Act"). This press release is neither an offer to sell nor the solicitation of an offer to buy the Vylor Notes or any other securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which, or to any person to whom, such an offer, solicitation or sale is unlawful. The Exchange Offers and Consent Solicitations have not been and will not be registered under the Securities Act, or the securities laws of any other jurisdiction, and, accordingly, the Vylor Notes will be subject to transfer restrictions unless and until the Vylor Notes are registered or exchanged for registered notes. The Vylor Notes will be issued in reliance upon exemptions from, or in transactions not subject to, registration under the Securities Act. The Exchange Offers and Consent Solicitations are being made only to, and the Vylor Notes will be offered for exchange only to, holders of EIDP Notes who are (i) reasonably believed to be "qualified institutional buyers" (as defined in Rule 144A under the Securities Act) in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act, and (ii) outside the United States, persons who are not, and who are not acting for the account or benefit of, "U.S. persons" (as defined in Rule 902 under the Securities Act) in compliance with Regulation S under the Securities Act. The Vylor Notes will not be offered or sold in the United States or to U.S. persons (as defined in Rule 902 under the Securities Act) unless the transaction is registered under the Securities Act, an exemption from the registration requirements of the Securities Act is available or the transaction is not subject to registration under the Securities Act.

The Exchange Offers and Consent Solicitations are being made only pursuant to the Offering Memorandum. The Offering Memorandum and other documents relating to the Exchange Offers and Consent Solicitations will be distributed only to holders of EIDP Notes who confirm that they are within the categories of eligible participants in the Exchange Offers and Consent Solicitations. None of Vylor, its directors or officers, the dealer managers and solicitation agents, the exchange agent, the information agent, the trustees for the Vylor Notes or the EIDP Notes, their respective affiliates, or any other person is making any recommendation as to whether holders should tender their EIDP Notes in the Exchange Offers or deliver related consents to the Proposed Amendments in the Consent Solicitations.

The complete terms and conditions of the Exchange Offers and Consent Solicitations are set forth in the Offering Memorandum. The Exchange Offers and Consent Solicitations are only being made pursuant to the Offering Memorandum. The Exchange Offers and Consent Solicitations are not being made to holders of EIDP Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY OTHER REGULATORY BODY HAS REGISTERED, RECOMMENDED OR APPROVED OF THE VYLOR NOTES OR PASSED UPON THE ACCURACY OR ADEQUACY OF THE OFFERING MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

About Corteva

Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

Cautionary Statement on Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the U.S. federal securities laws about the Company, Vylor, EIDP, the Exchange Offers and Consent Solicitations and the Separation, including but not limited to all statements about the timing and consummation of the Exchange Offers and Consent Solicitations and the Separation, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current assumptions regarding future business and financial performance and, by their nature, address matters that are uncertain to different degrees. You can identify forward-looking statements by the use of words such as "plans," "expects," "will," "anticipates," "believes," "intends," "projects," "estimates," "outlook" or other words of similar meaning. These forward-looking statements are subject to risks and uncertainties that could cause actual results to be materially different from those set forth in such forward-looking statements, including but not limited to, the risk: (i) that general economic and capital markets conditions may adversely affect the Exchange Offers and Consent Solicitations or the Separation; (ii) that the conditions to the Exchange Offers and Consent Solicitations or the Separation, including the receipt of the Requisite Consents, may not be satisfied or waived; (iii) that any event, change or other circumstance could give rise to the termination of the Exchange Offers and Consent Solicitations and/or the Separation; (iv) of the effects that any termination of the Separation may have on the Company or its subsidiaries; (v) that legal proceedings may be instituted related to the Separation or otherwise; (vi) of unexpected costs, charges or expenses; and (vii) of other risks and uncertainties described in the Company's and EIDP's filings with the U.S. Securities and Exchange Commission (the "SEC"), including under the heading "Risk Factors" (Item 1A) in the Company's most recently filed Annual Report on Form 10-K and in the Company's subsequent Quarterly Reports on Form 10-Q, and in other documents that the Company or EIDP files or furnishes with the SEC. Neither the Company nor EIDP undertakes any obligation to update or revise any forward-looking statement, except as required by applicable law.

SOURCE Corteva Agriscience

Release Date: July 31, 2026For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Strong first-hal

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.

While many investors like to look for momentum in stocks, this can be very tough to define. There is a lot of debate surrounding which metrics are the best to focus on and which are poor quality indicators of future performance. The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.

Below, we take a look at Corteva, Inc. (CTVA - Free Report) , a company that currently holds a Momentum Style Score of A. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score.

It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Corteva, Inc. currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.

You can see the current list of Zacks #1 Rank Stocks here >>>

Set to Beat the Market?Let's discuss some of the components of the Momentum Style Score for CTVA that show why this agriculture shows promise as a solid momentum pick.

Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It is also useful to compare a security to its industry, as this can help investors pinpoint the top companies in a particular area.

For CTVA, shares are up 2.23% over the past week while the Zacks Agriculture - Operations industry is down 0.7% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 4.13% compares favorably with the industry's 0.19% performance as well.

While any stock can see its price increase, it takes a real winner to consistently beat the market. That is why looking at longer term price metrics -- such as performance over the past three months or year -- can be useful as well. Shares of Corteva, Inc. have increased 12.99% over the past quarter, and have gained 23.86% in the last year. In comparison, the S&P 500 has only moved 3.48% and 18.18%, respectively.

Investors should also pay attention to CTVA's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. CTVA is currently averaging 3,285,966 shares for the last 20 days.

Earnings OutlookThe Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's price movement. Investors should note that earnings estimates are also significant to the Zacks Rank, and a nice path here can be promising. We have recently been noticing this with CTVA.

Over the past two months, 3 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost CTVA's consensus estimate, increasing from $3.72 to $3.76 in the past 60 days. Looking at the next fiscal year, 2 estimates have moved upwards while there have been no downward revisions in the same time period.

Bottom LineTaking into account all of these elements, it should come as no surprise that CTVA is a #2 (Buy) stock with a Momentum Score of A. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep Corteva, Inc. on your short list.

Corteva, Inc. stands as a global leader in pure agri-tech, emphasizing R&D for advanced seed genetics and sustainable crop solutions. My prior Hold ratings on CTVA underestimated the market's preference for quality, execution, and improved business visibility over strict valuation metrics. CTVA has significantly outperformed the broader market by four times and its ETF peers by more than two times since my earlier reviews.

For the quarter ended June 2026, Corteva, Inc. (CTVA - Free Report) reported revenue of $6.38 billion, down 1.2% over the same period last year. EPS came in at $2.30, compared to $2.20 in the year-ago quarter.

The reported revenue represents a surprise of -3.66% over the Zacks Consensus Estimate of $6.62 billion. With the consensus EPS estimate being $2.24, the EPS surprise was +2.68%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Corteva, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Net Sales- Crop Protection: $1.85 billion versus $1.93 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -3.8% change.Net Sales- Seed: $4.53 billion compared to the $4.66 billion average estimate based on three analysts. The reported number represents a change of -0.1% year over year.Net Sales- Seed- Other oilseeds: $228 million versus $223.97 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +22.6% change.Net Sales- Crop Protection- Biologicals: $86 million compared to the $96.01 million average estimate based on two analysts.Net Sales- Crop Protection- Herbicides: $932 million versus $1.01 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -6.3% change.Net Sales- Crop Protection- Insecticides: $399 million compared to the $436.24 million average estimate based on two analysts. The reported number represents a change of -8.5% year over year.Net Sales- Crop Protection- Fungicides: $263 million versus $326.08 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -23.1% change.Net Sales- Crop Protection- Other: $167 million versus the two-analyst average estimate of $57.9 million. The reported number represents a year-over-year change of +240.8%.Net Sales- Seed- Soybean: $1.32 billion versus $1.4 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +4.9% change.Net Sales- Seed- Corn: $2.87 billion versus $2.83 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -3.1% change.Net Sales- Seed- Other: $118 million versus $162.14 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -11.3% change.Operating EBITDA- Seed: $1.97 billion versus the three-analyst average estimate of $1.92 billion.View all Key Company Metrics for Corteva, Inc. here>>>

Shares of Corteva, Inc. have returned +8.3% over the past month versus the Zacks S&P 500 composite's -1.5% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Seed 1H results reflect continued value capture on latest in-demand germplasm and trait technologies, including licensing growth Crop Protection 1H demand for new products and focus on operational excellence helped offset competitive pricing dynamics Full-year 2026 guidance3 increased to reflect strong first half performance, incremental benefits on controllable levers, and growth platforms Corteva remains on-track to complete the planned separation, targeting October 1 Vylor spin-off date , /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the second quarter and six months ended June 30, 2026.

2Q 2026 Results Overview

Net Sales

Inc. from Cont. Ops (After Tax)

EPS

GAAP

$6.38B

$1.22B

$1.81

vs. 2Q 2025

(1) %

(12) %

(10) %

Organic1 Sales

Operating EBITDA1

Operating EPS1

NON-GAAP

$6.32B

$2.26B

$2.30

vs. 2Q 2025

(2) %

4 %

5 %

1H 2026 Results Overview

Net Sales

Inc. from Cont. Ops (After Tax)

EPS

GAAP

$11.28B

$1.94B

$2.88

vs. 1H 2025

4 %

(5) %

(3) %

Organic1 Sales

Operating EBITDA1

Operating EPS1

NON-GAAP

$11.05B

$3.70B

$3.80

vs. 1H 2025

2 %

10 %

14 %

First Half 2026 Highlights

Net sales increased 4% versus prior year. Organic1 sales increased 2% in the same period with gains in almost all regions. Seed net sales increased 4% and organic1 sales increased 3%. Price/mix was up 3% led by North America2 and EMEA2 with continued execution on the Company's price for value strategy and increased royalty income. Volume was flat, primarily reflecting the shift from corn to soy in North America2 and timing shifts in Latin America. Crop Protection net sales increased 3% and organic1 sales decreased 1%. Volume increased 2%, driven by demand for new products. Price declined 3% primarily due to the market dynamics in Latin America. GAAP income and earnings per share (EPS) from continuing operations were $1.94 billion and $2.88 per share, respectively. Operating EBITDA1 and Operating EPS1 were $3.70 billion, and $3.80 per share, respectively. The Company updated full-year 2026 guidance3 and expects Operating EBITDA1 to be in the range of $4.1 to $4.3 billion.  Operating EPS1 is expected to be $3.60 to $3.80 per share.  1. Organic Sales, Operating EPS, and Operating EBITDA are non-GAAP measures. See page 7 for further discussion. 2. North America is defined as U.S. and Canada. EMEA is defined as Europe, Middle East and Africa. 3. The Company does not provide the most comparable GAAP measure on a forward-looking basis. See page 6 for further discussion.  4. One-time separation costs do not include deferred asset expenses related to debt issuance costs to be amortized/incurred as future interest payments.

______________________________________________________________________________________

"Our strong first half was fueled by demand for next-gen Seed technologies, differentiated Crop Protection products, and focused execution. This level of performance, combined with our company-wide focus on productivity, cost discipline and operational excellence, allowed us to deliver continued margin expansion.  Given these results, and our confidence in the opportunities ahead, we are raising our full-year guidance. 

We also continue to make meaningful progress toward the planned separation, an important milestone that will create two focused, industry-leading companies with enhanced strategic flexibility and ambition to continue to create sustainable value for farmers, customers, shareholders, and employees. As we begin the second half of the year, our focus remains where it should be: on our customers, on delivering the year and on ensuring the separation on October 1 is both timely and smooth. I'm excited to see what the future holds for both companies."

Chuck Magro
Chief Executive Officer

______________________________________________________________________________________

Company Updates

Separation Update: Key Milestone Targets

Corteva remains on track to complete the planned separation on October 1, 2026, with already announced key milestones Appointment of both companies' Board of Directors Form 10 public filing available – due to regulatory requirements, Vylor is shown as the continuing operations of Corteva, Inc. with New Corteva presented as discontinued operations Both companies reviewed capital structure submissions with the credit rating agencies Net dis-synergies largely offset on run-rate basis; $25 million headwind included in full-year 2026 guidance given timing of separation-related activities Key separation milestones expected to be achieved in the second half of 2026: Board of Directors' approval of final capital structures Form 10 goes effective Webcasted Investor Day events at New York Stock Exchange on September 15, 2026 Vylor operating as separate public company on October 1, 2026 Summary of Second Quarter 2026

For the second quarter ended June 30, 2026, net sales decreased 1% versus the same period last year. Organic1 sales decreased 2%.

Volume was down 3% versus prior year. Crop Protection volume decreased 2% over the prior year driven primarily by timing shifts in North America.  Seed volume decreased 3% versus prior year due primarily to timing shifts in North America and Latin America, coupled with corn acre declines in North America and EMEA that were partially offset by higher soybean acres in North America and higher sunflower acres in EMEA.

Price/mix was up 1% versus prior year, reflecting higher Seed pricing, partially offset by competitive price dynamics in Crop Protection, primarily in Latin America.

GAAP income from continuing operations after income taxes was $1.22 billion in second quarter of 2026 compared to $1.38 billion in second quarter of 2025. Operating EBITDA1 for the second quarter of 2026 was $2.26 billion, up 4% compared to prior year, translating into over 190 basis points of Operating EBITDA1 margin improvement.

2Q

2Q

%

%

($ in millions, except where noted)

2026

2025

Change

Organic1 
Change

Net Sales

$6,379

$6,456

(1) %

(2) %

North America

$4,548

$4,629

(2) %

(2) %

EMEA

$730

$747

(2) %

(4) %

Latin America

$679

$672

1 %

(7) %

Asia Pacific

$422

$408

3 %

8 %

1H

1H

%

%

($ in millions, except where noted)

2026

2025

Change

Organic1 
Change

Net Sales

$11,284

$10,873

4 %

2 %

North America

$6,987

$6,839

2 %

2 %

EMEA

$2,385

$2,224

7 %

1 %

Latin America

$1,185

$1,114

6 %

(3) %

Asia Pacific

$727

$696

4 %

7 %

Seed Summary

Seed net sales were $4.53 billion in the second quarter of 2026, flat with the second quarter of 2025. This reflects a 3% increase in price/mix, offset by a 3% decrease in volume.

The increase in price/mix is due primarily to demand for top technology and increased out-licensing income. Volume declines in the quarter were due to timing shifts in North America and Brazil, coupled with the acreage shift from corn to soy in North America and corn to sunflower in EMEA.

Segment operating EBITDA was $1.97 billion in the second quarter of 2026, up 6% from the second quarter of 2025. Price/mix, reductions in net royalty expense, and ongoing cost and productivity actions more than offset lower volumes and increased R&D and functional cost.  Segment operating EBITDA margin improved by over 230 basis points versus the prior-year period.

2Q

2Q

%

%

($ in millions, except where noted)

2026

2025

Change

Organic1 Change

North America

$3,955

$3,954

- %

- %

EMEA

$272

$282

(4) %

(4) %

Latin America

$160

$154

4 %

(5) %

Asia Pacific

$145

$147

(1) %

7 %

Total 2Q

Seed Net Sales

$4,532

$4,537

- %

- %

2Q Seed Operating 
EBITDA

$1,966

$1,863

6 %

N/A

Seed net sales were $7.56 billion in the first half of 2026, up 4% from the same period of 2025. The sales increase reflects a 3% increase in price/mix and a 1% favorable currency impact.

Price/mix gains in all regions, led by North America, demonstrate demand for top technology and the strength of the portfolio, coupled with increased out-licensing income. Volumes were flat, as higher soybean area in North America was offset by lower corn area in North America and timing shifts in Latin America. Favorable currency impacts were led by the Euro and the Brazilian Real, partially offset by the Turkish lira.

Segment operating EBITDA was $3.00 billion for the first half of 2026, up 11% from the same period of 2025. Price/mix execution, reductions in net royalty expense, and ongoing cost and productivity actions more than offset increased selling, admin and R&D expense, including higher bad debt. Segment operating EBITDA margin improved by over 235 basis points versus the prior-year period.

1H

1H

%

%

($ in millions, except where noted)

2026

2025

Change

Organic1 Change

North America

$5,725

$5,551

3 %

3 %

EMEA

$1,200

$1,108

8 %

3 %

Latin America

$384

$339

13 %

2 %

Asia Pacific

$246

$246

- %

6 %

Total 1H

Seed Net Sales

$7,555

$7,244

4 %

3 %

1H Seed Operating 
EBITDA

$3,000

$2,705

11 %

N/A

Crop Protection Summary

Crop Protection net sales were approximately $1.85 billion in the second quarter of 2026 compared to approximately $1.92 billion in the second quarter of 2025. The sales decrease over the prior period reflects a 4% price decline and a 2% decrease in volume, partially offset by a 2% favorable impact from currency.

The decrease in volume was driven primarily by channel purchase timing in North America, coupled with dry weather in EMEA and partially offset by broad-based volume growth in Asia Pacific. The price decline was primarily due to the competitive pricing environment in Latin America.  Favorable currency impacts were led by the Brazilian Real and the Euro.

Segment operating EBITDA was $342 million in the second quarter of 2026, up 2% from the second quarter of 2025. Cost and productivity actions along with currency more than offset the unfavorable impact of volume and price pressure. Segment operating EBITDA margin improved by over 110 basis points versus the prior-year period.

2Q

2Q

%

%

($ in millions, except where noted)

2026

2025

Change

Organic1 Change

North America

$593

$675

(12) %

(12) %

EMEA

$458

$465

(2) %

(4) %

Latin America

$519

$518

- %

(7) %

Asia Pacific

$277

$261

6 %

8 %

Total 2Q Crop 
Protection Net Sales

$1,847

$1,919

(4) %

(6) %

2Q Crop Protection
Operating EBITDA

$342

$334

2 %

N/A

Crop Protection net sales were approximately $3.73 billion for the first half of 2026 compared to approximately $3.63 billion in the same period of 2025. The sales increase reflects a 2% increase in volume and a 4% favorable impact from currency, partially offset by a 3% decline in price.

The price decline was primarily due to market dynamics in Latin America. The increase in volume was driven by demand for new products, partially offset by channel purchase timing in North America. Favorable currency impacts were led by the Euro and the Brazilian Real.

Segment operating EBITDA was $776 million for the first half of 2026, up 9% from the same period last year. Cost and productivity actions, currency, and volume growth more than offset the unfavorable impact of price pressure and higher selling and admin expense.  Segment operating EBITDA margin improved by over 120 basis points versus the prior-year period.

1H

1H

%

%

($ in millions, except where noted)

2026

2025

Change

Organic1 Change

North America

$1,262

$1,288

(2) %

(3) %

EMEA

$1,185

$1,116

6 %

(1) %

Latin America

$801

$775

3 %

(5) %

Asia Pacific

$481

$450

7 %

7 %

Total 1H Crop 
Protection Net Sales

$3,729

$3,629

3 %

(1) %

1H Crop Protection
Operating EBITDA

$776

$711

9 %

N/A

2026 Guidance

Strong demand remains the defining feature of the agricultural landscape, supporting overall fundamentals across key crop markets. Farmers will continue to prioritize investments that enhance productivity and returns, driving adoption of advanced genetics, and differentiated crop protection products. While trade, currency movements, and weather will continue to influence market conditions, the overall environment remains grounded in durable end-market consumption.

Against this backdrop, our full-year outlook remains positive. Seed demand continues to be supported by strong adoption of our differentiated technologies, while Crop Protection benefits from normalized channel inventories and improving industry fundamentals. Stabilizing farm economics continue to support farmer investment in solutions that drive yield improvement and profitability.

As a result of these market dynamics and coupled with our strong first half execution, the Company increased full-year 2026 guidance3 with Operating EBITDA1 expected to be $4.1 billion to $4.3 billion, growth of 9% at the mid-point. Operating EPS1 is expected to be $3.60 to $3.80 per share, growth of 11% at the mid-point.

The Company is not able to reconcile its forward-looking non-GAAP financial measures, to its most comparable U.S. GAAP financial measures, as it is unable to predict with reasonable certainty items outside of its control, such as Significant Items, without unreasonable effort.

Second Quarter Conference Call

The Company will host a live webcast of its second quarter 2026 earnings conference call with investors to discuss its results and outlook tomorrow, July 31, 2026, at 9:00 a.m. ET. The slide presentation that accompanies the conference call is posted on the Company's Investor Events and Presentations page. A replay of the webcast will also be available on the Investor Events and Presentations page.

About Corteva

Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

Cautionary Statement About Forward-Looking Statements

This press release contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like "plans," "expects," "will," "anticipates," "believes," "intends," "projects," "estimates," "outlook," or other words of similar meaning. All statements that address expectations or projections about the future, including  statements about Corteva's financial results or outlook; strategy for growth; product development; regulatory approvals; market position; capital allocation strategy; liquidity; sustainability targets and initiatives; the anticipated benefits of acquisitions, restructuring actions, or cost savings initiatives; the anticipated benefits, impacts, and timing of the Proposed Separation; and the outcome of contingencies, such as litigation and environmental matters, are forward-looking statements.

Forward-looking statements and other estimates are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements and other estimates also involve risks and uncertainties, many of which are beyond Corteva's control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Corteva's business, results of operations and financial condition. Some of the important factors that could cause Corteva's actual results to differ materially from those projected in any such forward-looking statements include: (i) failure to obtain or maintain the necessary regulatory approvals for some of the company's products; (ii) failure to successfully develop and commercialize the company's pipeline; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of the company's biotechnology and other agricultural products; (iv) failure to comply with competition and antitrust laws; (v) effect of changes in agricultural and related policies of governments and international organizations; (vi) costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements; (vii) effect of climate change and unpredictable seasonal and weather factors; (viii) effect of competition in Corteva's industry; (ix) competitor's establishment of an intermediary platform for distribution of Corteva's products; (x) risks related to recent funding and staff reductions at U.S. government agencies; (xi) risk related to geopolitical and military conflict; (xii) effect of volatility in Corteva's input costs; (xiii) risks related to Corteva's global operations; (xiv) effect of industrial espionage and other disruptions to Corteva's supply chain, information technology or network systems;  (xv) risks related to environmental litigation and the indemnification obligations of legacy EIDP liabilities in connection with the Corteva Separation; (xvi) impact of Corteva's dependence on third parties with respect to certain of its raw materials or licenses and commercialization; (xvii) failure of Corteva's customers to pay their debts to Corteva, including customer financing programs; (xviii) failure to effectively manage acquisitions, divestitures, alliances, restructurings, cost savings initiatives, and other portfolio actions; (xix) failure to raise capital through the capital markets or short-term borrowings on terms acceptable to Corteva; (xx) increases in pension and other post-employment benefit plan funding obligations; (xxi) risks related to pandemics or epidemics; (xxii) capital markets sentiment towards sustainability matters; (xxiii) Corteva's intellectual property rights or defense against intellectual property claims asserted by others; (xxiv) effect of counterfeit products; (xxv) Corteva's dependence on intellectual property cross-license agreements; (xxvi) risks related to Corteva's Separation from DowDuPont; and (xxvii) risks related to Corteva's Proposed Separation, including, but not limited to, whether the objectives of the proposed separation will be achieved; the terms, structure, benefits and costs of any action or transaction resulting from the proposed separation; the timing of any such separation or related action and whether any such separation will be consummated at all; the risk that the proposed separation could divert the attention and time of the company's management; the risk of any unexpected costs or expenses resulting from the proposed separation process or separation itself; and the risk of any litigation as a result of, or relating to, the Proposed Separation.

Additionally, there may be other risks and uncertainties that Corteva is unable to currently identify or that Corteva does not currently expect to have a material impact on its business. Where, in any forward-looking statement or other estimate, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Corteva's management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" in Corteva's annual and quarterly reports filed on Forms 10-K and 10-Q with the U.S. Securities and Exchange Commission.

Regulation G (Non-GAAP Financial Measures)

This earnings release includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. These measures may include organic sales, organic growth (including by segment and region), operating EBITDA, operating earnings (loss) per share, and base income tax rate. Management uses these measures internally for planning and forecasting, including allocating resources and evaluating incentive compensation. Management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year over year results. These non-GAAP measures supplement the Company's U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Reconciliations for these non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures starting on page A-5 of the Financial Statement Schedules.

Corteva is not able to reconcile its forward-looking non-GAAP financial measures to its most comparable U.S. GAAP financial measures, as it is unable to predict with reasonable certainty items outside of the Company's control, such as significant items, without unreasonable effort. For significant items reported in the periods presented, refer to page A-10 of the Financial Statement Schedules. Beginning January 1, 2020, the Company presents accelerated prepaid royalty amortization expense as a significant item. Accelerated prepaid royalty amortization represents the non-cash charge associated with the recognition of upfront payments made to Monsanto in connection with the Company's non-exclusive license in the United States and Canada for Monsanto's Genuity® Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits. Due to the ramp-up of Enlist E3™, Corteva significantly reduced the volume of products with the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits beginning in 2021, with expected minimal use of the trait platform thereafter. The Company committed to restructuring activities to optimize the Crop Protection network of manufacturing and external partners, which are expected to be substantially complete in 2028. The Company expects to record approximately $140 million to $150 million net pre-tax restructuring charges during 2026 for these activities.

Organic sales is defined as price and volume and excludes currency and portfolio and other impacts, including significant items. Operating EBITDA is defined as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items and separation costs. Non-operating benefits (costs) consists of non-operating pension and other post- employment benefit (OPEB) credits (costs), tax indemnification adjustments, and environmental remediation and legal costs associated with legacy businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the Company as pre-tax income or expense. 

Operating earnings (loss) per share is defined as "earnings (loss) per common share from continuing operations - diluted" excluding the after-tax impact of significant items, the after-tax impact of separation costs, the after-tax impact of non-operating benefits (costs), the after-tax impact of amortization expense associated with intangible assets existing as of the Corteva Separation from DowDuPont, and the after-tax impact of net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Although amortization of the Company's intangible assets is excluded from these non-GAAP measures, management believes it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in amortization of additional intangible assets. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the relevant non-GAAP financial measures, allowing quarterly results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items, separation costs, amortization of intangibles (existing as of Corteva Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and non-operating (benefits) costs.

® TM Corteva Agriscience and its affiliated companies.

7/30/2026

SOURCE Corteva Agriscience

Key Takeaways Corteva's two businesses offer investors distinct growth, margin and risk drivers.Seed organic sales rose 9%, EBITDA climbed 23% and margin expanded about 310 basis points.Crop Protection volumes rose 6% as cost savings helped lift total operating EBITDA 21%. Corteva, Inc. (CTVA - Free Report) gives investors exposure to two agriculture technology businesses with different earnings drivers. Seed accounts for 56.9% of total company net sales, while Crop Protection contributes 43.1%.

That balance matters as the company moves toward a planned fourth-quarter 2026 separation. The split could lead investors to value each business on its own growth, margin and risk profile.

Corteva’s Two Engines Support a Balanced Growth StorySeed and Crop Protection address separate farmer needs. Seed focuses on germplasm and traits that support yield potential and resistance to weather, disease, pests and herbicides. Crop Protection supplies products that protect crops from weeds, insects, other pests and disease.

Image Source: Zacks Investment Research

Both segments are tied to the same farm economy. Crop acreage, commodity prices, farmer income, weather, seasonal planting patterns, currency moves and regional input demand all influence results. The mix can provide resilience when one business faces weaker pricing or seasonal pressure.

That context matters for peers, too. Bayer AG (BAYRY - Free Report) competes across seed, crop protection and digital farming, making it a useful comparison for integrated agriculture technology exposure. FMC Corporation (FMC - Free Report) , with its crop protection focus, offers a cleaner read on chemical demand and pricing conditions.

CTVA Seed Pricing Strengthens Revenue QualityCorteva’s Seed business delivered 9% organic sales growth in the first quarter of 2026. Price and product mix improved 3%, with gains across all regions, reflecting demand for differentiated technologies and value-based pricing.

This is not simply an acreage story. Brevant retail brand growth, licensing momentum, productivity savings and lower royalty costs are improving revenue quality. Seed operating EBITDA increased 23%, and segment margin expanded about 310 basis points.

Royalty economics are becoming a clearer earnings lever. Corteva recorded a roughly $30 million reduction in net royalty expense in the quarter and now expects Seed to become royalty positive in 2026, ahead of its earlier royalty-neutral target.

Corteva’s Crop Protection Volumes Offset Price PressureCrop Protection showed a different pattern. First-quarter revenues rose 10%, while organic sales increased 4%. Volumes improved 6%, with gains in every region, supported by demand for new products and spinosyn insecticides.

Pricing remains the offset. Segment price declined 2%, mainly due to competitive market dynamics in Latin America and Asia Pacific. Management expects low-single-digit Crop Protection pricing pressure to continue through 2026.

The volume picture still supports the segment’s role in Corteva’s portfolio. Herbicide sales increased 19%, insecticide revenues rose 12% and fungicide sales improved 10% in the quarter. Sustained margin improvement will still depend on mix, productivity and cost control.

CTVA's Cost Savings Expand the Earnings RunwayCorteva’s cost actions are extending the earnings runway beyond volume recovery. Operating EBITDA increased 21% year over year to $1.44 billion in the first quarter, while operating EBITDA margin expanded about 240 basis points to more than 29%.

The company generated roughly $70 million of combined productivity and input-cost benefits across Seed and Crop Protection. Lower Seed royalty costs added another tailwind, helping offset higher selling, general and administrative expenses.

Image Source: Zacks Investment Research

Management reaffirmed its 2026 operating EBITDA outlook of $4.0 billion to $4.2 billion, representing growth of about 7% at the midpoint. The company is also running ahead of its prior three-year, $1 billion cost-reduction plan.

Corteva’s Buy Signal Meets Mixed Style ScoresThe bottom line is that Corteva’s two-engine model gives investors both technology-led Seed growth and Crop Protection volume leverage. The planned separation may sharpen that view by allowing the market to evaluate Vylor and the future Corteva separately.

CTVA currently carries a Zacks Rank #2 (Buy), which points to favorable near-term earnings estimate trends. That is a constructive signal for investors who rely on earnings estimate revisions over the next one to three months. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Style Scores are more mixed. CTVA has a Value Score of D, Growth Score of D and VGM Score of D, suggesting the stock does not screen well across those factors. Its Momentum Score of A aligns with recent outperformance, but the weaker Value, Growth and VGM scores argue for a balanced view.

The upcoming report from Corteva, Inc. (CTVA - Free Report) is expected to reveal quarterly earnings of $2.24 per share, indicating an increase of 1.8% compared to the year-ago period. Analysts forecast revenues of $6.62 billion, representing an increase of 2.6% year over year.

The consensus EPS estimate for the quarter has undergone a downward revision of 89.9% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.

Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.

Bearing this in mind, let's now explore the average estimates of specific Corteva, Inc. metrics that are commonly monitored and projected by Wall Street analysts.

According to the collective judgment of analysts, 'Net Sales- Crop Protection' should come in at $1.93 billion. The estimate suggests a change of +0.5% year over year.

Analysts predict that the 'Net Sales- Seed' will reach $4.66 billion. The estimate suggests a change of +2.7% year over year.

The consensus among analysts is that 'Net Sales- Seed- Other oilseeds' will reach $223.97 million. The estimate indicates a year-over-year change of +20.4%.

The average prediction of analysts places 'Net Sales- Crop Protection- Herbicides' at $1.01 billion. The estimate indicates a year-over-year change of +1%.

The combined assessment of analysts suggests that 'Net Sales- Crop Protection- Insecticides' will likely reach $436.24 million. The estimate indicates a change of +0.1% from the prior-year quarter.

It is projected by analysts that the 'Net Sales- Crop Protection- Fungicides' will reach $326.08 million. The estimate points to a change of -4.7% from the year-ago quarter.

Based on the collective assessment of analysts, 'Net Sales- Crop Protection- Other' should arrive at $57.90 million. The estimate points to a change of +18.2% from the year-ago quarter.

The collective assessment of analysts points to an estimated 'Net Sales- Seed- Soybean' of $1.40 billion. The estimate indicates a year-over-year change of +11.2%.

Analysts forecast 'Net Sales- Seed- Corn' to reach $2.83 billion. The estimate points to a change of -4.4% from the year-ago quarter.

Analysts expect 'Net Sales- Seed- Other' to come in at $162.14 million. The estimate indicates a change of +21.9% from the prior-year quarter.

Analysts' assessment points toward 'Operating EBITDA- Seed' reaching $1.92 billion. The estimate is in contrast to the year-ago figure of $1.86 billion.

The consensus estimate for 'Operating EBITDA- Crop Protection' stands at $324.27 million. Compared to the present estimate, the company reported $334.00 million in the same quarter last year.

View all Key Company Metrics for Corteva, Inc. here>>>

Over the past month, shares of Corteva, Inc. have returned +5.1% versus the Zacks S&P 500 composite's +1.7% change. Currently, CTVA carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Posted by Defense World Staff on Jul 27th, 2026

First Trust Advisors LP reduced its stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 43.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 596,194 shares of the company’s stock after selling 465,569 shares during the quarter. First Trust Advisors LP owned 0.09% of Corteva worth $49,907,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CTVA. Brighton Jones LLC raised its holdings in Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after purchasing an additional 11,760 shares during the period. Woodline Partners LP raised its stake in Corteva by 40.3% in the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Corteva by 62.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock worth $191,000 after buying an additional 980 shares in the last quarter. Cresset Asset Management LLC lifted its stake in Corteva by 2.6% in the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after purchasing an additional 181 shares in the last quarter. Finally, Jump Financial LLC purchased a new stake in shares of Corteva in the second quarter valued at approximately $1,464,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Wall Street Analysts Forecast Growth A number of research firms have weighed in on CTVA. Royal Bank Of Canada boosted their price objective on Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 21st. Oppenheimer boosted their price target on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research report on Thursday. CICC Research upped their price objective on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. BNP Paribas Exane raised their price objective on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Finally, Jefferies Financial Group boosted their target price on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $90.19.

Get Our Latest Research Report on CTVA

Corteva Trading Down 0.0% NYSE CTVA opened at $89.23 on Monday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The firm has a market cap of $59.68 billion, a price-to-earnings ratio of 52.49, a PEG ratio of 2.70 and a beta of 0.56. The firm has a 50 day simple moving average of $81.39 and a 200-day simple moving average of $78.99. Corteva, Inc. has a one year low of $60.53 and a one year high of $89.39.

Corteva (NYSE:CTVA – Get Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.32. The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts anticipate that Corteva, Inc. will post 3.76 EPS for the current fiscal year.

Corteva Dividend Announcement The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Corteva’s dividend payout ratio is currently 42.35%.

Key Headlines Impacting Corteva Here are the key news stories impacting Corteva this week:

Positive Sentiment: Oppenheimer raised its price target on Corteva to $95 from $89 and kept an “outperform” rating, signaling confidence in further upside for the stock. Positive Sentiment: Zacks upgraded Corteva to Rank #2 (Buy), citing improving earnings prospects ahead of the company’s upcoming results. Positive Sentiment: Analysts expect Q2 earnings growth as premium seed demand, new products, and productivity gains help offset pricing and inflation pressure. Corteva Set to Report Q2 Earnings: What Investors Should Expect Neutral Sentiment: Corteva declared a quarterly dividend of $0.18 per share, payable September 15 to shareholders of record on September 1, which supports the stock’s income profile but is not a major growth catalyst. Corteva Declares Quarterly Dividend Neutral Sentiment: The company is set to report Q2 earnings soon, and investors are awaiting confirmation that demand and operating efficiency trends are holding up. Corteva (CTVA) Projected to Release Quarterly Earnings on Thursday Corteva Profile (Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Recommended Stories Five stocks we like better than Corteva RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade? These 4 Earnings Reports Expose the Market’s Growing Economic Divide Broadcom May Be the Biggest Winner From Alphabet’s Earnings Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEFirst Trust Advisors LP Sells 265,601 Shares of Meta Platforms, Inc. $META

NEXT HEADLINE »First Trust Advisors LP Has $53.23 Million Position in Otter Tail Corporation $OTTR

Key Takeaways Corteva's Q2 EPS estimate is $2.22, up 0.91%, while revenues of $6.61B imply a 2.4% decline.Premium seeds, disciplined pricing and favorable product mix are expected to support Seed revenues.Productivity and lower input costs may cushion pricing, inflation and geopolitical pressures. Corteva, Inc. (CTVA - Free Report) is likely to witness growth in its top and bottom lines when it reports second-quarter fiscal 2026 results on July 30, after the opening bell. The Zacks Consensus Estimate for quarterly revenues is pegged at $6.61 billion, indicating a 2.4% dip from the prior-year quarter’s figure.

The Zacks Consensus Estimate for earnings is pegged at $2.22 per share, which indicates growth of 0.91% from the year-ago quarter’s registered numbers. The consensus mark has increased by 2 cents over the past 30 days.

CTVA delivered an earnings surprise of 27.1% in the last reported quarter. In the trailing four quarters, the company’s earnings beat the Zacks Consensus Estimate by 25.3%.

Key Factors to Influence CTVA’s Q2 ResultsCorteva's second-quarter 2026 performance is likely to have benefited from healthy demand across its Seed business, supported by favorable planting conditions in North America and continued adoption of premium seed technologies. Management indicated that farmers continued to prioritize high-yielding hybrids and trait technologies despite a cautious spending environment, with strong demand for Pioneer products, Brevant retail offerings and Enlist soybean technology. The company also noted that pricing discipline and favorable product mix across regions are expected to remain supportive of Seed revenues.

Crop Protection revenues are also likely to have benefited from continued volume growth, driven by robust demand for differentiated products and biological solutions. Corteva has been witnessing strong momentum in new products and spinosyn insecticides across regions, while management expects Latin America to remain a key growth driver. Increasing adoption of biological products, including Utrisha and BlueN, along with favorable pest pressure, is likely to have supported volumes during the quarter, partly offsetting ongoing pricing pressure in the Crop Protection business.

Margin performance is likely to have benefited from Corteva's continued focus on productivity initiatives and lower input costs. Management expects productivity gains across both the Seed and Crop Protection businesses, while lower seed commodity costs and improving royalty economics should continue to aid profitability. The company's progress toward becoming royalty-positive, coupled with disciplined cost management, is expected to have provided a meaningful cushion against higher selling expenses and ongoing investments in the business.

However, the quarter is likely to have been affected by persistent pricing pressure in Crop Protection, particularly in Latin America, amid a competitive market environment. In addition, higher oil prices, geopolitical uncertainties and inflationary pressures remain challenges, although management stated that tariff trends have been somewhat more favorable than previously anticipated and mitigation efforts are underway. While these headwinds are expected to have weighed on profitability, strong operational execution and resilient demand for Corteva's premium technologies are likely to have partly offset their impact.

What the Zacks Model Unveils for CTVAOur proven model conclusively predicts an earnings beat for CTVA this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is exactly the case here.

Corteva currently has an Earnings ESP of +4.81% and a Zacks Rank of 3. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.

Valuation Picture of CTVA StockThe company has a forward 12-month price-to-earnings ratio of 22.73X, which is above the Agriculture - Operations industry’s average of 16.13X.

Image Source: Zacks Investment Research

The recent market movements show that CTVA shares have risen 11.8% in the past three months compared with the industry's 12.9% growth.

Image Source: Zacks Investment Research

Other Stocks With the Favorable CombinationHere are some other companies worth considering, as our model shows that these also have the right combination of elements to beat on earnings this reporting cycle.

Kimberly-Clark Corporation (KMB - Free Report) currently has an Earnings ESP of +1.43% and a Zacks Rank of 3. The Zacks Consensus Estimate for Kimberly-Clark’s upcoming quarterly revenues is pegged at $4.23 billion. The figure implies a 1.7% increase from the prior-year quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Kimberly-Clark’s quarterly earnings per share (EPS) is pegged at $2, indicating a 4.2% gain from the year-ago period figure. KMB delivered a trailing four-quarter earnings surprise of 19.1%, on average.

Archer-Daniels-Midland Company (ADM - Free Report) currently has an Earnings ESP of +11.52% and a Zacks Rank of 2. The consensus estimate for ADM’s quarterly revenues is pinned at $22.38 billion, which calls for 5.7% growth from the figure reported in the prior-year quarter.

The Zacks Consensus Estimate for Archer-Daniels’ quarterly EPS is pegged at $1.27, which implies a 36.6% rise year over year. ADM delivered a trailing four-quarter earnings surprise of 5.4%, on average.

Monster Beverage Corporation (MNST - Free Report) currently has an Earnings ESP of +2.61% and a Zacks Rank of 3. The consensus estimate for revenues is pinned at $2.42 billion, which suggests 14.5% growth from the figure reported in the prior-year quarter.

The Zacks Consensus Estimate for Monster Beverage’s quarterly EPS is pegged at 59 cents, which implies a 13.5% increase year over year. MNST delivered a trailing four-quarter earnings surprise of 9.6%, on average.

Posted by Defense World Staff on Jul 23rd, 2026

ABN Amro Investment Solutions decreased its stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 59.4% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 63,821 shares of the company’s stock after selling 93,474 shares during the quarter. ABN Amro Investment Solutions’ holdings in Corteva were worth $5,342,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock. Drummond Knight Asset Management Pty Ltd acquired a new stake in shares of Corteva during the 4th quarter worth about $25,713,000. Arbejdsmarkedets Tillaegspension acquired a new position in Corteva in the 4th quarter valued at about $23,679,000. Mirae Asset Global Investments Co. Ltd. grew its stake in Corteva by 23.5% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock valued at $7,378,000 after buying an additional 20,957 shares during the last quarter. Leonteq Securities AG bought a new position in Corteva in the 4th quarter valued at about $2,350,000. Finally, Brandes Investment Partners LP lifted its position in Corteva by 1.1% during the fourth quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock worth $155,009,000 after acquiring an additional 24,985 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Wall Street Analyst Weigh In CTVA has been the subject of a number of research analyst reports. Wells Fargo & Company boosted their price objective on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Barclays lifted their price target on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a report on Thursday, June 11th. Jefferies Financial Group boosted their price target on Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Morgan Stanley upped their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Finally, BNP Paribas Exane boosted their target price on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $89.90.

Discover more

Military satellite technology

Defense industry events

Business Finance

Check Out Our Latest Research Report on CTVA

Corteva Price Performance Shares of NYSE:CTVA opened at $88.56 on Thursday. The firm has a 50 day moving average of $81.13 and a 200-day moving average of $78.69. The stock has a market capitalization of $59.23 billion, a PE ratio of 52.09, a PEG ratio of 2.64 and a beta of 0.56. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $88.57.

Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same quarter last year, the business posted $1.13 EPS. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts predict that Corteva, Inc. will post 3.75 EPS for the current fiscal year.

Corteva Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date was Monday, June 1st. Corteva’s payout ratio is currently 42.35%.

Corteva Profile (Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Articles Five stocks we like better than Corteva Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINE6,000 Shares in American Tower Corporation $AMT Bought by AR Asset Management Inc.

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. reduced its holdings in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 6.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 274,132 shares of the company’s stock after selling 18,258 shares during the quarter. Amova Asset Management Americas Inc.’s holdings in Corteva were worth $22,948,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. lifted its stake in Corteva by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after purchasing an additional 317,538 shares during the last quarter. State Street Corp lifted its position in shares of Corteva by 3.7% during the 4th quarter. State Street Corp now owns 36,570,876 shares of the company’s stock worth $2,451,346,000 after buying an additional 1,290,071 shares during the last quarter. Franklin Resources Inc. lifted its position in shares of Corteva by 4.3% during the 4th quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock worth $1,309,599,000 after buying an additional 805,873 shares during the last quarter. Harris Associates L P boosted its holdings in shares of Corteva by 168.1% in the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after buying an additional 10,675,052 shares in the last quarter. Finally, Northern Trust Corp grew its position in shares of Corteva by 5.0% in the 4th quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock valued at $786,385,000 after buying an additional 562,550 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Price Performance Shares of NYSE:CTVA opened at $86.85 on Tuesday. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The company has a market cap of $58.09 billion, a P/E ratio of 51.09, a PEG ratio of 2.67 and a beta of 0.56. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $88.21. The company has a 50-day moving average price of $80.94 and a 200 day moving average price of $78.40.

Corteva (NYSE:CTVA – Get Free Report) last released its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. The company had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a $0.18 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Corteva’s payout ratio is 42.35%.

Wall Street Analysts Forecast Growth Several equities analysts have issued reports on the stock. Mizuho upped their price objective on shares of Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research note on Tuesday, July 14th. Berenberg Bank lifted their price target on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research report on Thursday, March 26th. Morgan Stanley boosted their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. The Goldman Sachs Group raised their target price on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Finally, Bank of America upped their price target on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $89.62.

View Our Latest Stock Analysis on Corteva

About Corteva (Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Recommended Stories Five stocks we like better than Corteva The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINERoyal Bank Of Canada Issues Positive Forecast for Fifth Third Bancorp (NASDAQ:FITB) Stock Price

NEXT HEADLINE »Amova Asset Management Americas Inc. Has $39.56 Million Holdings in Archer Aviation Inc. $ACHR

Karen Grimes to be Chair; separation on track for 4Q 2026

, /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today the board of directors for Vylor Inc., the future publicly traded, advanced seed and genetics company that will result from the current company's planned separation.

Karen Grimes will lead the board as Independent Chair. Grimes joined Corteva's board of directors in March 2021 and was previously senior managing director, partner, and equity portfolio manager at Wellington Management Company LLP, an investment management firm. She began her career as a field engineer in the Atlanta office at IBM after serving for three years in the U.S. Army. Grimes also serves as a director of Toll Brothers, Inc., a company that develops and builds luxury residential communities across the U.S., since March 2019.

"Vylor will be a company dedicated to leveraging its expertise in advanced seed and genetics to help farmers feed and fuel the world. I look forward to working with my fellow directors as well as the Vylor senior management team to accelerate the company's growth and impact – and continue to deliver results for shareholders," said Grimes.

The appointments to the board of seven directors will be effective at separation, which remains on track for the fourth quarter of 2026. A search is ongoing for at least one additional board member.

The Future Vylor Board of Directors

Karen Grimes, retired partner, senior managing director and equity portfolio manager, Wellington Management Company, non-executive chair of the board Victor Aguilar, chief research, development and innovation officer, The Procter & Gamble Company Rajesh "Raj" Kalathur, Rajesh "Raj" Kalathur, former president, John Deere Financial, former chief information officer and chief financial officer, Deere & Company Marcos Lutz, chairman, former chief executive officer, Ultrapar Participacões S.A. Chuck Magro, future chief executive officer, Vylor Johannes "Jannie" J. Oosthuizen, executive vice president and president, oncology and MSD International, Merck & Co., Inc. Kerry Preete, retired executive vice president and chief strategy officer, Monsanto Company Vylor's innovation engine will be anchored in the agriculture industry's most elite germplasm and transformative biotech. The company will leverage its next generation scientific expertise in disciplines like gene editing and molecular breeding to further strengthen its core business while exploring opportunities to expand to new row crops – and potentially beyond. Vylor will scale these innovations using its leading routes-to-market and by significantly expanding its licensing business.

About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

Cautionary Statement on Forward-Looking Statements
This press release contains certain forward-looking statements. Words such as "will," "plan," "may," "expect," "see," and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, Corteva's intent to separate and its related expectations for Corteva and Vylor. These forward-looking statements reflect management's current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond Corteva's control.

Important factors that may affect Corteva's business and operations and that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, whether the objectives of the separation will be achieved; the terms, structure, benefits and costs of any action or transaction resulting from the separation; the timing of any such separation or related action and whether any such separation will be consummated at all; the risk that the announcement of the intended separation could have an adverse effect on the ability of Corteva to retain and hire key personnel and maintain relationships with customers, suppliers, employees, shareholders and other business relationships and on its operating results and business generally; the risk the separation could divert the attention and time of the company's management; the risk of any unexpected costs or expenses resulting from the separation process or separation itself; and the risk of any litigation relating to the separation, as well as the risks and uncertainties described in Corteva's risk factors, as they may be amended from time to time, set forth in its filings with the U.S. Securities and Exchange Commission. Corteva disclaims and does not undertake any obligation to update, revise, or withdraw any forward-looking statement in this press release, except as required by applicable law or regulation.

SOURCE Corteva Agriscience

Corteva, Inc. (CTVA) Presents at 3rd Annual Materials of the Future Conference Transcript

New directors replace retiring directors, bring food, agriculture and chemical expertise

, /PRNewswire/ -- Corteva, Inc. today announced that its shareholders have approved the addition of Christopher Policinski and Jean-Marc Gilson to its board of directors. As previously announced, Lamberto Andreotti and Michael Johanns retired with this year's annual meeting of shareholders. 

"We are pleased to welcome Chris and Jean-Marc to the Corteva Board – their expertise in the agriculture and chemicals sectors, respectively, will both strengthen the Board and serve Corteva well, particularly as the company moves forward with its plans to separate into two industry-leading companies," said Corteva Board Chair Gregory Page.

Page added, "On behalf of the entire Board, I want to thank Lamberto and Michael for their outstanding service to Corteva. Their efforts have helped guide Corteva to its current position of strength and laid a strong foundation for continued growth and success.  We wish them both the best in their new chapters."

As previously communicated, board of directors appointments for "SpinCo" and "New Corteva" will be made in the second half of 2026.

About Chris Policinski
Policinski is the former president and chief executive officer of Land O'Lakes, Inc., a privately held agricultural cooperative specializing in dairy products, animal nutrition, and crop production, from 2005 to 2018. He joined Land O'Lakes in 1997 and held a variety of key leadership positions, including vice president, strategy and business development; executive vice president, dairy foods; and chief operating officer, dairy foods. Policinski has served on the board of directors of Hormel Foods Corp. since 2012, and from 2016 to 2023 served as the lead independent director. He previously served on the board of directors of Xcel Energy Inc. from 2009 to 2025, where he was also the lead independent director from 2016 to 2023.

About Jean-Marc Gilson
Gilson is the president and chief executive officer and member of the board of directors of Westlake Corporation, a global manufacturer and supplier of vinyl, polymers and building products, a position he has held since July 2024. Prior to this appointment, he was the president and chief executive officer and member of the board of directors of Mitsubishi Chemical Group Corporation from April 2021 to June 2024. Previously, Gilson served as chief executive officer of Roquette Frères, a global leader in plant-based ingredients and pharmaceutical excipients, from 2014 to 2021; chief operating officer of NuSil Technology LLC, a leading manufacturer of medical and space-grade silicone technology, from 2012 to 2014; and as chief executive officer of Avantor Performance Materials, Inc. from 2011 to 2012. Earlier in his career, he held a variety of key leadership positions at the Dow Corning Corporation.

About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

Cautionary Statement on Forward-Looking Statements
This press release contains certain forward-looking statements. Words such as "will," "plan," "may," "expect," "see," and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, Corteva's intent to separate and its related expectations for New Corteva and SpinCo. These forward-looking statements reflect management's current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond Corteva's control.

Important factors that may affect Corteva's business and operations and that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, whether the objectives of the separation will be achieved; the terms, structure, benefits and costs of any action or transaction resulting from the separation; the timing of any such separation or related action and whether any such separation will be consummated at all; the risk that the announcement of the intended separation could have an adverse effect on the ability of Corteva to retain and hire key personnel and maintain relationships with customers, suppliers, employees, shareholders and other business relationships and on its operating results and business generally; the risk the separation could divert the attention and time of the company's management; the risk of any unexpected costs or expenses resulting from the separation process or separation itself; and the risk of any litigation relating to the separation, as well as the risks and uncertainties described in Corteva's risk factors, as they may be amended from time to time, set forth in its filings with the U.S. Securities and Exchange Commission. Corteva disclaims and does not undertake any obligation to update, revise, or withdraw any forward-looking statement in this press release, except as required by applicable law or regulation.

SOURCE Corteva, Inc.

New brand builds upon century-long legacy,  reflects ambition to advance science to feed and fuel the world INDIANAPOLIS, May 4, 2026 /PRNewswire/ -- Corteva (NYSE: CTVA) announced today that the company that will comprise its current advanced seed and genetics business, previously referred to as "SpinCo," will be branded Vylor, Inc. Corteva's planned separation remains on track for the fourth quarter of 2026. With more than 4,000 germplasm patents and more than 2,000 biotechnology patents, Vylor's innovation engine will be anchored in the industry's most elite germplasm and transformative biotechnology, including a world-class pipeline that includes gamechangers like proprietary hybrid wheat, leadership in gene editing, multi-disease resistance corn and next-generation biofuels.

Corteva, Inc. (CTVA) came out with quarterly earnings of $1.5 per share, beating the Zacks Consensus Estimate of $1.18 per share. This compares to earnings of $1.13 per share a year ago.

Corteva, Inc. (CTVA) Q1 2026 Earnings Call Transcript

Corteva NYSE: CTVA reported a stronger-than-expected start to 2026, with management pointing to broad demand for seed and crop protection products, favorable timing in North American seed deliveries and continued cost savings as key drivers of first-quarter earnings growth.